NCT04779424View on ClinicalTrials.gov

Prevalence and Incidence of Antibodies Against SARS-CoV-2 Among Primary Healthcare Providers in Belgium (COVID-19)

CompletedOBSERVATIONAL

Enrollment

3,390

Participants

Timeline

Start Date

November 15, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

March 31, 2023

Conditions

SARS-CoV-2COVID-19

Interventions

OTHER

POCT

Capillary blood sample antibody point of care test

Trial Locations (1)

2610

Niels Adriaenssens, Wilrijk

All Listed Sponsors

collaborator

Sciensano

OTHER_GOV

collaborator

University of Liege

OTHER

lead

Universiteit Antwerpen

OTHER

NCT04779424 - Prevalence and Incidence of Antibodies Against SARS-CoV-2 Among Primary Healthcare Providers in Belgium (COVID-19) | Biotech Hunter | Biotech Hunter